Navigation Links
Fish Oil and Red Yeast Rice Studied for Lowering Blood Cholesterol
Date:7/8/2008

ROCHESTER, Minn., July 8 /PRNewswire-USNewswire/ -- A great deal of scientific evidence shows that cholesterol-reducing medications known as statins can help prevent coronary artery disease. Although the safety of these medications has been well documented, as many as 40 percent of patients who receive a prescription for statins take the drug for less than one year. Doctors believe that several factors -- including cost, adverse effects, poor understanding of statin benefits and patients' reluctance to take prescription medications long term -- may explain why some patients stop taking these medicines. In the July issue of Mayo Clinic Proceedings, a group of researchers from Pennsylvania examine whether an alternative approach to treating high blood cholesterol may provide an effective treatment option for patients who are unable or unwilling to take statins.

Study design

Researchers followed 74 patients with high blood cholesterol who met standard criteria for using statin therapy. Patients were randomly assigned to either the alternative treatment group or the statin group and followed for three months.

The alternative treatment group participants received daily fish oil and red yeast rice supplements, and they were enrolled in a 12-week multidisciplinary lifestyle program that involved weekly 3.5-hour educational meetings led by a cardiologist, dietitian, exercise physiologist and several alternative or relaxation practitioners. Red yeast rice is the product of yeast grown on rice. A dietary staple in some Asian countries, it contains several compounds known to inhibit cholesterol production.

The statin group participants received 40 milligrams (mg) of Zocor (simvastatin) daily, as well as printed materials about diet and exercise recommendations. At the end of the three-month period, participants from both groups underwent blood cholesterol testing to determine the percentage change in LDL cholesterol.

Results

T
'/>"/>

SOURCE Mayo Clinic
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AdvanDx Submits Yeast Traffic Light PNA FISH(TM) for FDA 510(k) Clearance for Detection of Candida species in Positive Blood Cultures
2. Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis
3. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
4. New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
5. Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies
6. Blueberry-Supplemented Diet Shows Promise in Lowering Cholesterol in Animal Trials
7. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
8. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
9. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
10. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
11. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)....,Nov.24/PRNewswire/--SpartaSystems,Inc.,themakero...alityandcompliancesolutions,todayannouncedthatSSLI...mpanyandtheparentcompanyforgloballyrecognizedbrand...rpriseQualityManagementSystem(EQMS).Thecompanyisno...inequalityoperationsthatincludeCorrectiveandPreven...
(Date:11/24/2009)...Nov.24/PRNewswire-USNewswire/--America,spharmaceut...edicinesandvaccinestotreatorpreventHIV/AIDSandrela...thePharmaceuticalResearchandManufacturersofAmerica...DSDay"-aglobalawarenesscampaignthatoriginatedatthe...IDSPrevention. ,, "Wearegreatlyencouragedbythes...
(Date:11/24/2009)...ss.,Nov.24/PRNewswire-FirstCall/--EchoTherapeutics...needle-freeSymphony(TM)tCGMSystemasanon-invasive,w...M)systemanditsPrelude(TM)SkinPrepSystemfortransder...M.D.,ChairmanandChiefExecutiveOfficer,willpresenta...nference,sponsoredbytheNewYorkSocietyofSecuritiesA...
Breaking Medicine Technology:SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 2SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 3New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2Health Care Reform 3A Communicating Policy With Hispanic Media 61795 1Health Care Reform 3A Communicating Policy With Hispanic Media 61795 2Health Care Reform 3A Communicating Policy With Hispanic Media 61795 3Experts Examine Possible Links Between Climate Change and Infectious Disease Transmission 61793 1Experts Examine Possible Links Between Climate Change and Infectious Disease Transmission 61793 2Experts Examine Possible Links Between Climate Change and Infectious Disease Transmission 61793 3BD Completes Acquisition of HandyLab Inc 6428 1BD Completes Acquisition of HandyLab Inc 6428 2BD Completes Acquisition of HandyLab Inc 6428 3
...in McHale is,one of five board members to start th...ganization incorporated in Saint Paul, Minnesota. ...created to gift cochlear implants to,impoverished ... obtain one.,Dr. William House, the "true" invento...of Directors., While the burden of deafness on an...
...0:00 a.m. today, Thursday, August 16, 2007, MALVE...Nasdaq: AUXL ) today announced that the Company h...Administration ("FDA") to,resume its phase III cli...for injection), formerly referred to as AA4500, in...pany will hold a conference call today,August 16, ...
Other Medicine Technology:Kevin McHale Instrumental in Forming the 'Help Me Hear Foundation' 2Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 2Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 3Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 4Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 5Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 6
(Date:11/24/2009)...an recruiting firm LocumTenens.com, a leading prov...o announce its agreement with VHA Inc., a national...um tenens assignments. , ...cian recruiting firm LocumTenens.com , a leading...sed to announce its agreement with VHA Inc., a nat...
(Date:11/24/2009)...ewswire-USNewswire/--GovernorEdwardG.Rendelltodaya...fluwerevaccinatedduringtheweekendatpublichealthcli...tments. ,, "Withthefederalgovernmentunabletopro...ilabilityofH1N1vaccine,distributionhasbeenchalleng...theH1N1vaccinedistributionprocessinPennsylvania.Ho...
(Date:11/24/2009)...24/PRNewswire/--Nextmonth,UnitedHealthcarewilloffe...panic-AmericanseniorsunderstandthebasicsofMedicare...eeZumba®Goldclass,aLatin-infusedfitnessprogra...,andtango. ,, UnitedHealthcarewillofferthesesem...gedwhenlearningabouttheirhealthcareoptions. There...
(Date:11/24/2009)...Newswire-FirstCall/--HealthSouthCorporation(NYSE: ...ricaMerrillLynch2009CreditConferenceinNewYorkonDec...TreasurerEdFaywillbespeakingonThursday,Dec.3,2009,...llbeavailableat http://investor.healthsouth.com by... ,, HealthSouthisthenation,slargestproviderofi...
(Date:11/24/2009)...s heart prospects, but cancer risk remains , ...study offers yet more proof that smoking is a majo...cer. , Researchers followed 12,152 American and... and nonsmokers for three years. During that time,...e of cancer, 2.26 times more likely to die of hear...
Breaking Medicine News(10 mins):Health News:VHA Names LocumTenens.com as Preferred Physician Staffing Vendor 2Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Smokers Double Their Risk for Heart Disease 2
... This release offers details about L...ition,s Breastfeeding-Friendly Business Award. , ...er 4, 2008 -- LifeCare®, Inc. , longtime lead...ve Connecticut organizations to receive the Coalit...
..., Nov. 3 The Institutes for the Achievement,of Hu...of special needs,children from five continents wil...n Wyndmoor, Pennsylvania on December 1, 2008 to at...ved child to,the child who is almost normal but no...
...ES, N.J., Nov. 3 BD (Becton,Dickinson and Company...ny,announced today that it would present at the fo...r:, 2008 Annual Credit Suisse Healthcare Con..., A live webcast of BD,s presentations can be acc...
...Children Taking Medications for Blood Pressure, Ch...ion and Diabetes, ST. LOUIS, Nov. 3 America,s tw... 2 diabetes medications between 2002 and,2005, wit...(Logo: http://www.newscom.com/cgi-bin/prnh/200808...
..., Nov. 3 Robbins & Myers, Inc.,(NYSE: RBN ) anno...nnual,Industrial Conference on November 11, 2008. ...e, President and Chief Executive Officer, and Chri...otel in Chicago, Illinois. It will be webcast and,...
...ORONTO, Nov. 3 /PRNewswire-FirstCall/ - Bradmer Ph...icated to the development and,commercialization of....,Ezrin, President and Chief Executive Officer of ...10th - 12th at the New,York Palace Hotel. Dr. Ezri...
Other Medicine News:Health News:LifeCare Wins Breastfeeding-Friendly Business Award from Connecticut Breastfeeding Coalition 2Health News:Parenting Course at The Institutes for the Achievement of Human Potential Gives Parents the Tools to Help their Special Needs Kids Have a Fighting Chance 2Health News:Tweens and Teens Double Use of Diabetes Drugs 2Health News:Tweens and Teens Double Use of Diabetes Drugs 3Health News:Tweens and Teens Double Use of Diabetes Drugs 4Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 2Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 3
...UHTS), Analyst GT delivers unsurpassed multimode a...sfer of assays into screening from assay developme...yst AD and HT, fluorescence intensity, fluorescenc...scence, absorbance, as well as providing seamless ...
...Analyst HT smoothes the transfer of assays into HT...y performance of Analyst AD, fluorescence intensit...cence, luminescence, absorbance. Optimized for se...uding those from Beckman Coulter, Zymark, CRS and ...
...lopment and basic research, including a simple ins...ime required to move assays into HTS. Specifically...ment laboratories, Analyst AD delivers unparallele..., Fluorescence Polarization, Time-Resolved Fluores...
...oplate based multi-detection reader which incorpor...orescence Polarization , Fluorescence Intensity ,...minescence (flash and glow) , Absorbance ,It i...dioactive labeled applications:, , Ca2+ Measuremen...
Medicine Products: